WATERMAN ROBERT A 4

Accession 0001209191-21-008355

CIK 0000860730other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 8:32 PM ET

Size

31.7 KB

Accession

0001209191-21-008355

Form 4

Period: 2021-02-03

SVP & General Counsel

Transactions

Exercise/Conversion
Common Stock
2021-02-03$22.95/sh+125,000$2,868,750→ 395,246 total
Exercise/Conversion
Common Stock
2021-02-03$47.97/sh+64,750$3,106,058→ 547,746 total
Sale
Common Stock
2021-02-05$177.38/sh−62,936$11,163,342→ 344,099 total
Exercise/Conversion
Stock Appreciation Right
2021-02-03−62,500→ 0 total
Exercise: $22.95Exp: 2022-02-08→ Common Stock (62,500 underlying)
Exercise/Conversion
Stock Appreciation Right
2021-02-03−45,000→ 0 total
Exercise: $37.18Exp: 2023-02-06→ Common Stock (45,000 underlying)
Exercise/Conversion
Common Stock
2021-02-03$37.18/sh+87,750$3,262,545→ 482,996 total
Tax Payment
Common Stock
2021-02-03$173.12/sh−140,711$24,359,888→ 407,035 total
Exercise/Conversion
Stock Appreciation Right
2021-02-03−62,500→ 0 total
Exercise: $22.95Exp: 2022-02-08→ Common Stock (62,500 underlying)
Exercise/Conversion
Stock Appreciation Right
2021-02-03−42,750→ 0 total
Exercise: $37.18Exp: 2023-02-06→ Common Stock (42,750 underlying)
Exercise/Conversion
Stock Appreciation Right
2021-02-03−35,000→ 0 total
Exercise: $47.97Exp: 2024-02-05→ Common Stock (35,000 underlying)
Exercise/Conversion
Stock Appreciation Right
2021-02-03−29,750→ 0 total
Exercise: $47.97Exp: 2024-02-05→ Common Stock (29,750 underlying)
Award
Stock Appreciation Right
2021-02-03+18,830→ 18,830 total
Exercise: $173.12From: 2022-02-03Exp: 2031-02-03→ Common Stock (18,830 underlying)

Footnotes (8)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.00 to $177.59, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F2]The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013.
[F3]The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.
[F4]The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.
[F5]The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.
[F6]The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
[F7]The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.
[F8]The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022.

Documents

2 files

HCA Healthcare, Inc.

CIK 0000860730

Entity typeother